(Q43007751)

12 November 2017

Photodynamic therapy for corneal neovascularisation and lipid degeneration (English)

1 reference

12 November 2017

1 reference

B J Brooks

1

1 reference

12 November 2017

B K Ambati

series ordinal

2

1 reference

12 November 2017

D M Marcus

series ordinal

3

1 reference

12 November 2017

A Ratanasit

series ordinal

4

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

British Journal of Ophthalmology

12 November 2017

1 reference

12 November 2017

88

1 reference

12 November 2017

6

1 reference

12 November 2017

840

1 reference

Photodynamic therapy of corneal neovascularization with verteporfin.

12 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772199

Treatment parameters for selective occlusion of experimental corneal neovascularization by photodynamic therapy using a water soluble photosensitizer, ATX-S10(Na).

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772199

Photodynamic therapy for corneal neovascularization using topically administered ATX-S10 (Na).

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772199

Photodynamic therapy for corneal neovascularization.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772199

26 May 2018

Identifiers

DOI

10.1136/BJO.2003.035071

1 reference

12 November 2017

1 reference

12 November 2017

PubMed publication ID

15148229

1 reference